Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multidrug combination therapy for cancerous neuropathic pain
ChiCTR2100045843Phase 4Recruiting
- Sponsor
- Jilin Provincial People's Hospital
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of etoricoxib, morphine and pregabalin in neuropathic cancer pain (NCP) (2 arms), sponsored by Jilin Provincial People's Hospital. Primary endpoint: Numerical Rating Scale (NRS) pain score. Started May 2021; status: recruiting.
02
Drugs
etoricoxibmorphinepregabalin
03
Conditions
neuropathic cancer pain (NCP)
Beyond the preview
Go deeper on ChiCTR2100045843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100045843.